Home » Topics » Articles » Insight

Insight
RSS

Venture Capital And Corporate Investments In Biotechnology Companies: September 2003

Oct. 6, 2003

Money Raised By Month

Oct. 6, 2003

Telik Gains Phase III Momentum; Prodrug Next Wave In Oncology?

Oct. 6, 2003

By Randy Osborne

Money Raised Year To Date

Oct. 6, 2003

Stock Indexes

Oct. 6, 2003

BioWorld Stock Report For Public Biotechnology Companies

Oct. 6, 2003

Stock Winners and Losers For The Week

Oct. 6, 2003

Stock Winners and Losers For The Week

Sep. 29, 2003

Correction

Sep. 29, 2003

Biotech - Big Pharma Collaborations New Agreements, July 24 - Sept. 24, 2003

Sep. 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...